Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by William L. Clarke
Results of a Second Year of Therapy With the 12-Month Histrelin Implant for the Treatment of Central Precocious Puberty
International Journal of Pediatric Endocrinology
Child Health
Endocrinology
Perinatology
Pediatrics
Metabolism
Diabetes
Modeling Insulin-Glucose Dynamics During Insulin Induced Hypoglycemia. Evaluation of Glucose Counterregulation
Journal of Theoretical Medicine
Related publications
Experience With the Once-Yearly Histrelin (GnRHa) Subcutaneous Implant in the Treatment of Central Precocious Puberty
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Three-Month Sustained-Release Triptorelin (11.25 Mg) in the Treatment of Central Precocious Puberty
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Central Precocious Puberty: From Genetics to Treatment
Best Practice and Research in Clinical Endocrinology and Metabolism
Endocrinology
Metabolism
Diabetes
Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery
International Journal of Pediatric Endocrinology
Child Health
Endocrinology
Perinatology
Pediatrics
Metabolism
Diabetes
Central Precocious Puberty in a 3 Year-Old Girl With Phenylketonuria: A Rare Association?
BMC Endocrine Disorders
Medicine
Endocrinology
Metabolism
Diabetes
PREMATURE OVARIAN FAILURE (POF) FOLLOWING GnRH AGONIST (HISTRELIN) THERAPY FOR IDIOPATHIC CENTRAL ISOSEXUAL PRECOCIOUS PUBERTY (CPP) AND RUSSEL-SILVER DWARFISM (RSD). † 524
Pediatric Research
Child Health
Pediatrics
Perinatology
A Two Year Old Girl With Precocious Puberty: The Youngest Ever Age of Presentation
Journal of Medical Science And clinical Research
Timing for Discontinuation of Treatment With a Long-Acting Gonadotropin-Releasing Hormone Analog in Girls With Central Precocious Puberty.
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Central Precocious Puberty as a Complication of Therapy With Adrenocorticotropin (ACTH) and an Aromatase Inhibitor for Refractory Nephrotic Syndrome
Case Reports in Pediatrics
